Sedic M[au] - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Sedic M[au] - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2003	1
2005	2
2006	1
2007	1
2008	3
2009	2
2010	5
2011	4
2012	3
2014	4
2015	3
2016	4
2017	7
2018	8
2019	1
2020	5
2021	4
2023	2
2024	3

59 results

Page of 6

Results by year

Page 1

Proteomic study of medicinal mushroom extracts reveals antitumor mechanisms in an advanced colon cancer animal model via ribosomal biogenesis, translation, and metabolic pathways.

Jakopovic B, Horvatić A, Baranasic J, Car I, Oršolić N, Jakopovich I, Sedić M, Kraljević Pavelić S. Jakopovic B, et al. Among authors: sedic m. Front Pharmacol. 2024 Oct 18;15:1475102. doi: 10.3389/fphar.2024.1475102. eCollection 2024. Front Pharmacol. 2024. PMID: 39494346 Free PMC article.

The Simultaneous Inhibition of Solute Carrier Family 6 Member 19 and Breast Cancer Resistance Protein Transporters Leads to an Increase of Indoxyl Sulfate (a Uremic Toxin) in Plasma and Kidney.

Wang Q, Munteanu B, Marker A, Luo Y, Holz C, Kane JL Jr, Kuntzweiler T, Poulton EJ, Sedic M, Jayyosi Z, Riedel J, Fretland J. Wang Q, et al. Among authors: sedic m. Drug Metab Dispos. 2024 Oct 16;52(11):1288-1296. doi: 10.1124/dmd.124.001813. Drug Metab Dispos. 2024. PMID: 39251367

Coumarin-modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells.

Jakopec S, Hamzic LF, Bočkor L, Car I, Perić B, Kirin SI, Sedić M, Raić-Malić S. Jakopec S, et al. Among authors: sedic m. Arch Pharm (Weinheim). 2024 Sep;357(9):e2400271. doi: 10.1002/ardp.202400271. Epub 2024 Jun 12. Arch Pharm (Weinheim). 2024. PMID: 38864840

Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro.

Car I, Dittmann A, Vasieva O, Bočkor L, Grbčić P, Piteša N, Klobučar M, Kraljević Pavelić S, Sedić M. Car I, et al. Among authors: sedic m. Int J Mol Sci. 2023 Aug 17;24(16):12906. doi: 10.3390/ijms241612906. Int J Mol Sci. 2023. PMID: 37629086 Free PMC article.

Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib.

Car I, Dittmann A, Klobučar M, Grbčić P, Kraljević Pavelić S, Sedić M. Car I, et al. Among authors: sedic m. Biology (Basel). 2023 Apr 17;12(4):608. doi: 10.3390/biology12040608. Biology (Basel). 2023. PMID: 37106808 Free PMC article.

Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding.

Maračić S, Grbčić P, Shammugam S, Radić Stojković M, Pavelić K, Sedić M, Kraljević Pavelić S, Raić-Malić S. Maračić S, et al. Among authors: sedic m. Molecules. 2021 Nov 22;26(22):7060. doi: 10.3390/molecules26227060. Molecules. 2021. PMID: 34834151 Free PMC article.

The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.

Grbčić P, Eichmann TO, Kraljević Pavelić S, Sedić M. Grbčić P, et al. Among authors: sedic m. Int J Mol Sci. 2021 Oct 5;22(19):10767. doi: 10.3390/ijms221910767. Int J Mol Sci. 2021. PMID: 34639107 Free PMC article.

Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation.

Bistrović Popov A, Vianelo R, Grbčić P, Sedić M, Pavelić SK, Pavelić K, Raić-Malić S. Bistrović Popov A, et al. Among authors: sedic m. Molecules. 2021 Jun 1;26(11):3334. doi: 10.3390/molecules26113334. Molecules. 2021. PMID: 34206076 Free PMC article.

Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib.

Grbčić P, Fučkar Čupić D, Gamberi T, Kraljević Pavelić S, Sedić M. Grbčić P, et al. Among authors: sedic m. Int J Mol Sci. 2021 Jun 8;22(12):6174. doi: 10.3390/ijms22126174. Int J Mol Sci. 2021. PMID: 34201061 Free PMC article.

Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs.

Rahman S, Wittine K, Sedić M, Markova-Car EP. Rahman S, et al. Among authors: sedic m. Molecules. 2020 Oct 26;25(21):4937. doi: 10.3390/molecules25214937. Molecules. 2020. PMID: 33114496 Free PMC article. Review.

59 results

Page of 6

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year